imipenem, anhydrous has been researched along with Body Weight in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, M; Kantesaria, B; Lala, M; Paschke, A; Rizk, ML; Walker, B | 1 |
| Chen, W; Harris, G; Kanzaki, G; Kuo Lee, R; Lam, CK; Patel, GB; Xu, HH | 1 |
| Andremont, A; Carbon, C; Massias, L; Montravers, P | 1 |
| Hashimoto, Y; Inui, KI; Kokuryo, T; Nakamura, T | 1 |
| Calandra, G; Carrigan, J; Guess, H; Lydick, E; Weiss, L | 1 |
2 trial(s) available for imipenem, anhydrous and Body Weight
| Article | Year |
|---|---|
Simplification of Imipenem Dosing by Removal of Weight-Based Adjustments.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Body Weight; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Imipenem; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Renal Insufficiency; Young Adult | 2019 |
Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: experience with imipenem/cilastatin.
Topics: Anti-Bacterial Agents; Bacterial Infections; Body Weight; Central Nervous System Diseases; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Cyclopropanes; Drug Combinations; Female; Humans; Imipenem; Kidney Function Tests; Male; Regression Analysis; Retrospective Studies; Risk Factors; Seizures; Thienamycins; Time Factors; United States | 1988 |
3 other study(ies) available for imipenem, anhydrous and Body Weight
| Article | Year |
|---|---|
A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Vaccines; Body Weight; Bronchopneumonia; Disease Models, Animal; Female; Imipenem; Immunization; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Pneumonia, Bacterial; Reproducibility of Results; Tigecycline; Time Factors | 2013 |
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 1994 |
Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats.
Topics: Acetylglucosaminidase; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Body Weight; Cilastatin; Cilastatin, Imipenem Drug Combination; Cisplatin; Creatinine; Dose-Response Relationship, Drug; Drug Combinations; Fosfomycin; Glomerular Filtration Rate; Imipenem; Kidney; Male; Nitrogen; Rats; Rats, Wistar; Vancomycin; Weight Gain | 1999 |